AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's ...
17h
Investor's Business Daily on MSNAstraZeneca Could Pay $4.5 Million In China Scandal. Here's Why Shares Jumped.AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.
AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...
AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities ...
A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super Bowl ...
Investors were reassured after the drugmaker said a potential fine in China would have only a minor business impact.The ...
17h
Pharmaceutical Technology on MSNAstraZeneca’s shares rise as it addresses China investigationIn addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...
AstraZeneca appointed a new president for its China operations following the arrest of former executive Leon Wang along with ...
The pharmaceutical giant's revenue jumped 21 per cent last year despite growing troubles over its presence in China, where it ...
This summary covers recent health news, including stable pig prices in Germany, investor focus on AstraZeneca's China probe, ...
AstraZeneca said the taxes related to two cancer drugs, Imfinzi and Imjudo, and that it was continuing to co-operate with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results